newsAbbVie’s Rinvoq® (upadacitinib) will be available on the NHS in…
14 January 2022 | By Hannah Balfour (European Pharmaceutical Review)
AbbVie’s Rinvoq® (upadacitinib) will be available on the NHS in England and Wales for adults with active psoriatic arthritis, following NICE approval.